Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP265926.RApe3pxr59INxklrEvDZhf7JQf_X-z28UmPecPuwGu4fg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP265926.RApe3pxr59INxklrEvDZhf7JQf_X-z28UmPecPuwGu4fg130_assertion type Assertion NP265926.RApe3pxr59INxklrEvDZhf7JQf_X-z28UmPecPuwGu4fg130_head.
- NP265926.RApe3pxr59INxklrEvDZhf7JQf_X-z28UmPecPuwGu4fg130_assertion description "[Two models of leukemia were used, one genetic (conditional alpha4 ablation of BCR-ABL1 [p210(+)] leukemia) and one pharmacological (anti-functional alpha4 antibody treatment of primary ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265926.RApe3pxr59INxklrEvDZhf7JQf_X-z28UmPecPuwGu4fg130_provenance.
- NP265926.RApe3pxr59INxklrEvDZhf7JQf_X-z28UmPecPuwGu4fg130_assertion evidence source_evidence_literature NP265926.RApe3pxr59INxklrEvDZhf7JQf_X-z28UmPecPuwGu4fg130_provenance.
- NP265926.RApe3pxr59INxklrEvDZhf7JQf_X-z28UmPecPuwGu4fg130_assertion SIO_000772 23319569 NP265926.RApe3pxr59INxklrEvDZhf7JQf_X-z28UmPecPuwGu4fg130_provenance.
- NP265926.RApe3pxr59INxklrEvDZhf7JQf_X-z28UmPecPuwGu4fg130_assertion wasDerivedFrom befree-20150227 NP265926.RApe3pxr59INxklrEvDZhf7JQf_X-z28UmPecPuwGu4fg130_provenance.
- NP265926.RApe3pxr59INxklrEvDZhf7JQf_X-z28UmPecPuwGu4fg130_assertion wasGeneratedBy ECO_0000203 NP265926.RApe3pxr59INxklrEvDZhf7JQf_X-z28UmPecPuwGu4fg130_provenance.